CPRT vs STRO · P/E 19, $28.66B cap vs rev $62.0M
Copart Inc (CPRT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
CPRT does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CPRT and STRO stock pages for the full models.
Not investment advice.